.jpg)
.png)
All
Abstract This case illustrates a common presentation of a rare phenomenon that should be highlighted so that clinicians are aware of the signs, implications, and management of LpX syndrome. Patient XY is a 30-year-old nonsmoker who was referred to our lipid clinic because of newly recognized... more
The NLA will be holding the following business meetings at the NLA Scientific Sessions in Miami, FL on May 16-19, 2019. Business meetings will take place on the general session stage and will include presentations of officer slates: Northeast Lipid Association (NELA) Business... more
Anyone in the Philadelphia area is welcome to join us for the Thursday February 20 PLAC (Philadelphia Lipid and Atherosclerosis Club) meeting: The 2013 ACC/AHA Guideline for Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: The Good, The Bad and the Ugly;... more
The National Lipid Association (NLA) recently elected new officers to serve a one-year term on its Board of Directors. The election came just prior to the organization’s Annual Scientific Sessions held May 1–4 in Orlando, Fla. The NLA is a nonprofit, multidisciplinary medical society... more
Greetings, NLA members, I hope all is well. The NLA has had a productive few months! Notable developments include the new, terrific edition of LipidSpin landing in your mailbox, the Pentathlon Challenge coming to a close, and the Annual Scientific Sessions in early June. Organized by my... more
The Very High ASCVD Risk Category Atherosclerotic cardiovascular disease (ASCVD) risk assessment has long been simplified to only several major risk factors and only a few categories, ranging from low to very high, despite the spectrum and magnitudes of risk factors and striking cumulative... more
The National Lipid Association has featured highlights from selected presentations at the 2016 Spring Clinical Lipid Update in San Diego. Read our meeting coverage here. more
By Batya Swift Yasgur, MA, LMSW In February of 2016, the National Lipid Association (NLA) released its Annual Summary of Clinical Lipidology, which is an update to Parts 1 and 2 of the NLA's “Recommendations for Patient-Centered Management of Dyslipidemia,” both published in 2015. The summary is... more